CWCharlotte E. Wittekind

Charlotte E. Wittekind

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Charlotte E. Wittekind has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Approach Bias Modification as an Add-On to Smoking Cessation Treatment: A Randomized Controlled Trial

    by Charlotte E. Wittekind, Keisuke Takano, Franziska Motka, Markus H. Winkler, Gabriela G. Werner, Thomas Ehring, Tobias Rüther

    Smoking is associated with an approach bias toward smoking-related stimuli. Approach bias modification (ApBM), a computerized training specifically designed to modify this approach bias, has shown positive effects in patients with alcohol use disorder; however, its efficacy as an add-on in smoking cessation treatment is inconclusive. The aim of this clinical trial was to investigate whether ApBM as an add-on to smoking cessation treatment results in higher 6-month prolonged abstinence rates compared to two control conditions. In this randomized, controlled, double-blind, single-center superiority trial, 351 participants received a 1-day cognitive-behavioral smoking cessation treatment (treatment as usual [TAU]) and were subsequently randomized to either TAU+ApBM (N=119), TAU+sham training (N=115), or TAU only (N=117). Training sessions were conducted over 7 days. The primary outcome was prolonged abstinence at 6-month follow-up. Participants were classified as either nonsmoking (continuous abstinence for 6 months, ≤5 cigarettes since quit attempt, and breath CO level ≤9 ppm) or relapsed (no objective verification of smoking status, breath CO level ≥10 ppm, >5 cigarettes since quit attempt). In the intention-to-treat analyses, abstinence rates at 6 months were 19.3% (95% CI=12.13, 26.53) for TAU+ApBM, 17.4% (95% CI=10.36, 24.42) for TAU+sham training, and 16.2% (95% CI=9.46, 23.02) for TAU only, with no significant differences between groups. This large-scale clinical trial demonstrates that TAU+ApBM is not significantly superior to TAU+sham training or TAU only. ApBM has been included in Australian and German alcohol use disorder treatment guidelines, but this randomized controlled trial shows that positive effects do not apply to tobacco use disorder.


  • Open Access

    Information processing biases in posttraumatic stress disorder (PTSD): cross-sectional findings and exploratory investigation of bias changes following treatment

    by Charlotte E. Wittekind, Maximilian Jäger, Anamaria Semm, Mina Stefanovic, Götz Berberich, Till Krauseneck, Thomas Ehring, Marcella L. Woud

    1. Posttraumatic Stress Disorder (PTSD) is a debilitating condition marked by persistent trauma-related memories, avoidance, negative thoughts and mood, and heightened arousal (American Psychiatric...

  • Open Access

    Understanding the link between maternal childhood maltreatment and mother-infant bonding: postpartum depressive symptoms as a mediator

    by Lea Vogel, Ulrike Lux, Tom Deliens, Thomas Ehring, Carmen Henning, Ansgar Opitz, Natalie Schoemann, Caroline Seiferth, Yannik Terhorst, Charlotte E. Wittekind, et al.

    Background: Impairments in mother-infant bonding (MIB) during the postpartum period were shown to adversely affect a child's development. Research suggests that such impairments are associated with mothers' own childhood experiences of maltreatment. Hence, understanding factors that mediate this relationship is essential for developing targeted preventive interventions to support mothers who experienced maltreatment in their own childhood during the perinatal period.Objective: As postpartum depression is associated with maternal experiences of childhood maltreatment and impairments in MIB, we aimed to examine the mediating effect of postpartum depression in the relationship between maternal experiences of childhood maltreatment and impairments in MIB.Methods: Longitudinal data from N = 128 mothers in the control group of an eHealth preventive intervention (I-PREGNO) were analysed. Using a path model, we investigated whether the association between maternal childhood maltreatment (measured by the Childhood Trauma Screener) and MIB (measured by the Postpartum Bonding Questionnaire) was mediated by postpartum depressive symptoms (measured by the Edinburgh Postnatal Depression Scale).Results: Postpartum depressive symptoms fully mediated the relationship between maternal experiences of childhood maltreatment and impairments in MIB (indirect effect [ab]: b = .44, p = .001, 95% CI [.18, .70]; direct effect [c']: b = .01, p = .953, 95% CI [-.38, .41]; total effect [c]: b = .45, p = .041, 95% CI [.02, .89]).Conclusion: Our results highlight the importance of addressing postpartum depression in mothers with childhood maltreatment experiences to promote MIB and to support a healthy start for the child.Trial registration: German Clinical Trials Register identifier: DRKS00031067.


  • Open Access

    Deficits in general and smoking‐specific response inhibition in the Go/No‐Go task in individuals who smoke: A cross‐sectional analysis

    by Franziska Motka, Simone Kühn, Charlotte E. Wittekind

    Background and aims: Previous studies on response inhibition deficits in smoking have often been conducted in small, young, age‐homogeneous samples, without controlling for covariates or testing moderating effects. The primary research question compared response inhibition between a large, age‐diverse smoking sample and non‐smoking controls, and examined whether deficits were exacerbated toward smoking‐related stimuli. By accounting for key covariates and moderators, this study aimed to extend understanding of individual differences in response inhibition deficits in smoking.Design and setting: Cross‐sectional study conducted at a university laboratory in Munich, Germany.Participants: The large (n = 122, 57% female), age‐diverse (Mage = 41.4, range: 21–70 years) smoking group comprised individuals with moderate to severe tobacco dependence participating in a smoking reduction intervention study. Controls comprised n = 69 healthy individuals with no smoking history.Measurements: Primary outcomes were commission error (CE) rates and mean reaction times in Go trials (Go‐RT) in general and smoking‐specific Go/No‐Go tasks (GNGTs). Covariates included age, sex and IQ. Smoking‐related variables were cigarettes per day (CPD), tobacco dependence severity and craving.Findings: General GNGT: The smoking group exhibited significantly higher CE rates (P‐value < 0.001, medium effect, BF10 = 9.06) than the control group. Higher craving was associated with faster Go‐RTs (β = −1.487, P‐value = 0.041). Smoking‐specific GNGT: CE rates were significantly higher in the smoking group only when controlling for covariates (β = 1.272, P‐value = 0.040). Higher craving was associated with higher CE rates during smoking‐related trials (β = 0.108, P‐value = 0.010). The smoking group showed significantly faster Go‐RTs in response to smoking‐related compared with neutral stimuli, relative to the control group (β = −3.326, P‐value = 0.027). Preliminary evidence indicated that greater deficits were associated with higher scores in smoking‐related variables, but only in older individuals.Conclusions: Individuals who smoke appear to exhibit response inhibition deficits, although these are not uniform and seem to be exacerbated during higher reported craving or in response to smoking‐related stimuli. Age may moderate the relationship between deficits and smoking‐related variables.


  • Open Access

    Dynamic symptom associations in posttraumatic stress disorder: a network approach

    by Mina Stefanovic, Keisuke Takano, Charlotte E. Wittekind, Thomas Ehring

    Background and objective: The current study aimed to investigate the within-day symptom dynamics in PTSD patients, specifically focusing on symptoms that most predict changes in other symptoms. The study included a baseline diagnostic assessment, followed by an assessment using the experience sampling method (ESM) via a smartphone.Method: Participants answered questions related to their PTSD symptoms four times per day for 15 consecutive days (compliance rate 75%). The clinical sample consisted of 48 treatment-seeking individuals: 44 with PTSD as a primary diagnosis, and four patients with subsyndromal PTSD, all of whom had not yet begun trauma-focused treatment. The ESM assessment included the 20 items from the PTSD Checklist for DSM-5, five items from the International Trauma Questionnaire (ITQ) assessing disturbances in relationships and functional impairment, and two items from the Clinician-Administered PTSD Scale for DSM-5 assessing symptoms of depersonalization and derealization.Results: Temporal networks (prospective associations between symptoms) showed that changes in hypervigilance predicted changes in the greatest number of symptoms at the next time point. Furthermore, hypervigilance showed temporal connections with at least one additional symptom from each of the DSM-5 PTSD symptom clusters.Conclusions: Results show that the contemporaneous network (representing the relationship between given symptoms within the same assessment occasion) and the temporal network (representing prospective associations between symptoms) differ and that it is important to estimate both. Some findings from earlier research are replicated, but heterogeneity across studies remains. Future studies should include potential moderators.


  • Open Access

    Comparing PTSD symptom networks in type I vs. type II trauma survivors

    by Mina Stefanovic, Thomas Ehring, Charlotte E. Wittekind, Birgit Kleim, Judith Rohde, Antje Krüger-Gottschalk, Christine Knaevelsrud, Heinrich Rau, Ingo Schäfer, Julia Schellong, et al.

    Background: Network analysis has gained increasing attention as a new framework to study complex associations between symptoms of post-traumatic stress disorder (PTSD). A number of studies have been published to investigate symptom networks on different sets of symptoms in different populations, and the findings have been inconsistent. Objective: We aimed to extend previous research by testing whether differences in PTSD symptom networks can be found in survivors of type I (single event; sudden and unexpected, high levels of acute threat) vs. type II (repeated and/or protracted; anticipated) trauma (with regard to their index trauma). Method: Participants were trauma-exposed individuals with elevated levels of PTSD symptomatology, most of whom (94%) were undergoing assessment in preparation for PTSD treatment in several treatment centres in Germany and Switzerland (n = 286 with type I and n = 187 with type II trauma). We estimated Bayesian Gaussian graphical models for each trauma group and explored group differences in the symptom network. Results: First, for both trauma types, our analyses identified the edges that were repeatedly reported in previous network studies. Second, there was decisive evidence that the two networks were generated from different multivariate normal distributions, i.e. the networks differed on a global level. Third, explorative edge-wise comparisons showed moderate or strong evidence for specific 12 edges. Edges which emerged as especially important in distinguishing the networks were between intrusions and flashbacks, highlighting the stronger positive association in the group of type II trauma survivors compared to type I survivors. Flashbacks showed a similar pattern of results in the associations with detachment and sleep problems (type II > type I). Conclusion: Our findings suggest that trauma type contributes to the heterogeneity in the symptom network. Future research on PTSD symptom networks should include this variable in the analyses to reduce heterogeneity.


  • Imagery Rescripting in der Behandlung der Posttraumatischen Belastungsstörung

    by Thomas Ehring, Eva Herzog, Charlotte E. Wittekind, Larissa Wolkenstein

    Imagery Rescripting ist eine in vielen psychotherapeutischen Richtungen und störungsspezifischen Behandlungsansätzen eingesetzte Technik, die auch im Rahmen der Therapie der Posttraumatischen Belastungsstörung (PTBS) Anwendung findet. Das Grundprinzip besteht in der imaginativen Aktivierung einer traumatischen Erinnerung, die in eine gezielte Veränderung des Geschehens in der Vorstellung mündet. Dieses Grundprinzip wird in verschiedenen Varianten und mit unterschiedlichen Zielen in der Behandlung der PTBS eingesetzt, unter anderem als Stand-Alone-Behandlung im Rahmen der Imagery Rescripting and Reprocessing Therapy (IRRT) sowie dem Imagery Rescripting für PTBS. In der Kognitiven Therapie der PTBS wird es darüber hinaus als spezifischer Baustein zur Aktualisierung der Traumaerinnerung verwendet. Andere Varianten wurden zur Behandlung von Albträumen oder zur Reduktion eines Gefühls des Beschmutzt-Seins nach sexueller Traumatisierung entwickelt. Nach einem vergleichenden Überblick über die unterschiedlichen Einsatzmöglichkeiten werden zusammenfassend Ergebnisse der Wirksamkeitsforschung dargestellt. Der Artikel schließt mit einem Ausblick auf aktuelle Entwicklungen und zukünftige Perspektiven in Bezug auf Indikation, differenzielle Wirksamkeit und Wirkmechanismen von Imagery Rescripting zur Behandlung der PTBS. Zur Illustration der dargestellten Interventionen werden in einem Online-Supplement zwei Fallbeispiele beschrieben.